Digestery
Longevity supplements › Fisetin and Aging › Studies

Systematic review

Review of three food compounds, fisetin among them, in Alzheimer's disease: authors say helpful

Gruendler and colleagues · Molecules (Basel, Switzerland) · 2020

Original title: Nutraceutical Approaches of Autophagy and Neuroinflammation in Alzheimer's Disease: A Systematic Review.

Under review. A person has not yet checked this summary against the paper. It is written from the PubMed abstract. Until a person checks it, search engines are asked not to list this page.

What the study found

Points to benefit

The authors say the reviewed substances, fisetin among them, looked helpful on cell clean-up, brain inflammation and cell aging. The abstract gives no numbers and no fisetin-only results.

The study at a glance

Type of study
Systematic review
Who or what was studied
studies on Alzheimer's disease; the abstract does not say if in people, animals or cells
What was tested
Review of three food-derived substances, including fisetin, and their effect on cell clean-up, brain inflammation and cell aging
What it measured
Lab tests or markers
Who has a stake
No stake declared
The authors declare no conflict of interest.
Journal
Molecules (Basel, Switzerland), 2020
Source
PubMed record 33353228. This page is based on the abstract only.

How much this study counts

  • •Sums up studies found with a set search method, without pooling the numbers.
  • –Measured lab tests or markers, which stand in for aging and senescent cells. A better marker does not always mean better health.
  • ✓No competing interests declared.
  • •Summarized from the PubMed abstract only. The full paper may hold details the abstract leaves out.

✓ Strength– Limit• Note

These points come from fixed rules about the type of study, its size and length, what it measured, and who has a stake. Every study on Digestery gets the same rules.

Where this study sits

This paper is not on the ladder. It is a systematic review, and reviews and opinion pieces discuss studies that are already counted on the steps below.

↑ Stronger evidence

  1. Trials in people: aging and age-related decline

    0

    Not done yet. This is the step that would answer the question.

  2. Trials in people: other measures

    0

    None among the papers we read.

  3. Trials in people: lab tests or safety

    0

    None among the papers we read.

  4. Population studies

    1

    1 benefit

  5. Blood levels and genes

    0

    None among the papers we read.

  6. Animals

    5

    5 benefit

  7. Cells in a dish

    1

    1 mixed

↓ Weaker evidence

  • Points to benefit
  • Mixed
  • No difference
  • No direction
  • Points to harm

How it fits with the other research

The short answer to “Does fisetin slow aging?”

Not shown in people.

Confidence: very low. Based on 12 on-topic papers.

Read the full answer
  • Summed up in “What reviews found”: Reviewed three food-derived substances, including fisetin, on Alzheimer's disease hallmarks: cell clean-up, brain inflammation and worn-out cells. Reported a positive outlook. The abstract gives no study count and no fisetin-only results.

Other reviews on this question

See all 12 studies on this question

How this page was made

Label

First read of the abstract
Claude Sonnet
Independent second read
Claude Haiku
Differences settled
The reviewer corrected 1 field after reading the abstract. Claude Opus 5.5.
Headline
Claude Sonnet, from the checked study record. A script checked its numbers and wording.
Numbers
Checked against the abstract by a script
“How much this study counts”
Fixed rules, the same for every study
Source check by a person
Not yet. Required before search engines may list this page.

Spot an error? Email a flag with a link to your source, or use the form on the question page.